TITLE

Evidence for interaction between clopidogrel and proton-pump inhibitors

AUTHOR(S)
Chua, Doson; Lo, Angela; Jung, Joanne
PUB. DATE
April 2010
SOURCE
American Journal of Health-System Pharmacy;4/15/2010, Vol. 67 Issue 8, p604
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Several letters to the editors are presented in response to articles in previous issues including "Review of Recent Evidence: Potential Interaction Between Clopidogrel and Proton Pump Inhibitors," by E. J. Last and Amy Heck Sheehan in the 2009 issue and a response by Last and Sheehan to it.
ACCESSION #
48959540

 

Related Articles

  • Interaction between clopidogrel and proton pump inhibitors: Literature to clinical practice. Hadi, Muhammad Abdul; Tan Chong Lip // Australasian Medical Journal;Jun2011, Vol. 4 Issue 6, p281 

    A letter to the editor is presented regarding the interaction between proton pump inhibitors (PPI) and clopidogrel.

  • Response to 'Drug Interactions Produced by Proton Pump Inhibitors: Not Simply a pH Effect'. Budha, N R; Benet, L Z; Ware, J A // Clinical Pharmacology & Therapeutics;Feb2013, Vol. 93 Issue 2, p151 

    A letter to the editor is presented in response to the article "Drug Interactions Produced by Proton Pump Inhibitors: Not Simply a pH Effect" that was published in the previous issue of the journal.

  • Coprescription of clopidogrel and proton pump inhibitors. Small, Gary R.; Chow, Benjamin J. W.; So, Derek Y. F. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/21/2011, Vol. 342 Issue 7807, p1096 

    The authors reflect on the safety and efficacy of the coprescription of clopidogrel and proton pump inhibitors. The authors state that the said coprescription is usually administered after an acute coronary event or percutaneous coronary intervention to lessen reinfarction and avoid in-stent...

  • Lack of association between proton pump inhibitors and adverse events in patients taking clopidogrel and aspirin. Waksman, Ron; Gaglia Jr., Michael A. // Evidence Based Medicine;Jun2013, Vol. 18 Issue 3, Following pe30 

    The authors comment on a study by Ron Waksman and colleagues to evaluate the association between clopidogrel and interaction with proton pump inhibitors (PPIs). The study found that no relationship existed between PPIs and adverse events in patients taking clopidogrel and aspirin. They commented...

  • Effects of Proton Pump Inhibitors in Patients Receiving Clopidogrel. van Oijen, Martijn G. H.; Siersema, Peter D. // Drug Safety;2011, Vol. 34 Issue 2, p173 

    A letter to the editor is presented in response to the study by Kwok et al. on the effect of proton pump inhibitors (PPI) in patients receiving Clopidogrel.

  • The Authors' Reply. Yoon Kong Loke; Chun Shing Kwok // Drug Safety;2011, Vol. 34 Issue 2, p174 

    A response by Yoon Kong Loke and Chun Shing Kwok is presented to a letter to the editor about their study on the effects of proton pump inhibitors in patients receiving clopidogrel.

  • Drug Regulatory Agencies' Role in the Interaction Between Clopidogrel and Proton Pump Inhibitors. Saiz, Luis Carlos; Álvarez, Jesús; Martínez, Henar // American Journal of Gastroenterology;Jul2011, Vol. 106 Issue 7, p1369 

    A letter to the editor is presented on the role of drug regulatory agencies in the interaction between Clopidogrel and Proton pump inhibitors (PPIs).

  • Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence. Mistry, Suresh D.; Trivedi, Hiren R.; Parmar, Dinesh M.; Dalvi, Prashant S.; Jiyo, Chacko // Indian Journal of Pharmacology;Apr2011, Vol. 43 Issue 2, p183 

    Clopidogrel is a prodrug which requires cytochrome P450 2C19 (CYP 2C19) enzyme for its conversion to an active thiol metabolite. Proton pump inhibitors (PPIs) inhibits enzyme CYP 2C19 interfering with the conversion of clopidogrel into its active metabolite. Studies document the possible...

  • PPIs and Clopidogrel: Do We Have to Worry?  // Critical Care Alert;Dec2009 Clinical Briefs in Primary, p23 

    The article focuses on the data which suggested that proton pump inhibitors (PPIs) should be avoided when treating acute coronary syndromes with clopidogrel or prasugrel.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics